Calculation
Operating profit margin | = | 100 | × | Operating profit1 | ÷ | Sales1 | |
---|---|---|---|---|---|---|---|
Dec 31, 2023 | 21.77% | = | 100 | × | 5,202) | ÷ | 23,890) |
Dec 31, 2022 | 27.61% | = | 100 | × | 8,688) | ÷ | 31,471) |
Dec 31, 2021 | 25.35% | = | 100 | × | 7,465) | ÷ | 29,453) |
Dec 31, 2020 | 18.99% | = | 100 | × | 4,231) | ÷ | 22,284) |
Dec 31, 2019 | 18.25% | = | 100 | × | 3,269) | ÷ | 17,911) |
Dec 31, 2018 | 17.11% | = | 100 | × | 3,404) | ÷ | 19,893) |
Dec 31, 2017 | 16.48% | = | 100 | × | 3,021) | ÷ | 18,330) |
Dec 31, 2016 | 16.29% | = | 100 | × | 2,751) | ÷ | 16,882) |
Dec 31, 2015 | 16.87% | = | 100 | × | 3,469) | ÷ | 20,563) |
Dec 31, 2014 | 17.23% | = | 100 | × | 3,431) | ÷ | 19,914) |
Dec 31, 2013 | 17.13% | = | 100 | × | 3,275) | ÷ | 19,118) |
Dec 31, 2012 | 17.33% | = | 100 | × | 3,165) | ÷ | 18,260) |
Dec 31, 2011 | 16.27% | = | 100 | × | 2,617) | ÷ | 16,091) |
Dec 31, 2010 | 16.41% | = | 100 | × | 2,166) | ÷ | 13,203) |
Dec 31, 2009 | 13.79% | = | 100 | × | 1,542) | ÷ | 11,185) |
Dec 31, 2008 | 14.72% | = | 100 | × | 1,869) | ÷ | 12,697) |
Dec 31, 2007 | 15.79% | = | 100 | × | 1,741) | ÷ | 11,026) |
Dec 31, 2006 | 15.82% | = | 100 | × | 1,518) | ÷ | 9,596) |
Dec 31, 2005 | 15.84% | = | 100 | × | 1,265) | ÷ | 7,985) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Danaher Corp. | AbbVie Inc. | Amgen Inc. | Gilead Sciences Inc. | Moderna Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|
Dec 31, 2023 | 21.77% | 23.49% | 29.35% | 28.24% | -63.54% | 30.85% | 16.00% |
Dec 31, 2022 | 27.61% | 31.21% | 38.57% | 27.17% | 51.10% | 38.93% | 18.69% |
Dec 31, 2021 | 25.35% | 31.89% | 31.44% | 36.72% | 75.22% | 55.67% | 25.57% |
Dec 31, 2020 | 18.99% | 24.81% | 37.70% | 16.72% | -381.82% | 42.09% | 24.19% |
Dec 31, 2019 | 18.25% | 39.03% | 43.57% | 19.38% | — | 28.10% | 17.99% |
Dec 31, 2018 | 17.11% | 19.49% | 45.55% | 37.83% | — | 37.77% | 15.53% |
Dec 31, 2017 | 16.48% | 33.99% | 45.76% | 55.04% | — | 35.41% | 14.19% |
Dec 31, 2016 | 16.29% | 36.60% | 44.74% | 58.87% | — | 27.38% | 13.40% |
Dec 31, 2015 | 16.87% | 32.97% | 40.44% | 69.03% | — | 30.51% | 13.77% |
Dec 31, 2014 | 17.23% | 17.09% | 32.03% | 62.37% | — | 29.74% | 14.82% |
Dec 31, 2013 | 17.13% | 30.14% | 32.25% | 41.87% | — | 36.11% | 12.30% |
Dec 31, 2012 | 17.33% | 31.65% | 33.52% | 42.67% | — | 33.20% | 11.85% |
Dec 31, 2011 | 16.27% | — | 28.19% | 46.77% | — | -46.02% | 10.62% |
Dec 31, 2010 | 16.41% | — | 37.82% | 53.62% | — | -21.23% | 11.72% |
Dec 31, 2009 | 13.79% | — | 38.37% | 54.55% | — | -19.54% | 10.38% |
Dec 31, 2008 | 14.72% | — | 35.50% | 52.68% | — | -37.67% | 11.71% |
Dec 31, 2007 | 15.79% | — | 27.81% | 57.98% | — | -91.55% | 10.00% |
Dec 31, 2006 | 15.82% | — | 27.71% | -29.32% | — | -169.68% | 6.38% |
Dec 31, 2005 | 15.84% | — | 40.33% | 61.41% | — | -187.97% | 10.01% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).